Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study

To determine whether gout and serum urate (SU) levels are associated with increased risk of death, time to first readmission for any cardiovascular event, or incident heart failure in individuals with cardiovascular disease.

[1]  M. Pillinger,et al.  Gout and cardiovascular disease: crystallized confusion , 2019, Current opinion in rheumatology.

[2]  Kenneth G Saag,et al.  Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout , 2018, The New England journal of medicine.

[3]  M. Bredemeier,et al.  Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials , 2018, BMC Cardiovascular Disorders.

[4]  Neha J. Pagidipati,et al.  An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome , 2017, American heart journal.

[5]  N. Dalbeth,et al.  Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. , 2017, Seminars in arthritis and rheumatism.

[6]  R. Doughty,et al.  C-Type Natriuretic Peptides in Coronary Disease. , 2017, Clinical chemistry.

[7]  Tom R. Gaunt,et al.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis , 2016, The lancet. Diabetes & endocrinology.

[8]  J. Danesh,et al.  Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. , 2016, Journal of the American College of Cardiology.

[9]  W. März,et al.  Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  Tom M Palmer,et al.  Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts , 2013, BMJ.

[11]  Hyon K. Choi,et al.  Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease , 2007, Circulation.

[12]  C. Frampton,et al.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.